Article Information
History
- April 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthew Bracher-Smith, PhD1,
- Ganna Leonenko, PhD2,
- Emily Baker, PhD2,
- Karen Crawford, MSc1,
- Andrew C. Graham, MSc3,
- Dervis A. Salih, PhD3,
- Brian W. Howell, PhD4,
- John Hardy, PhD3,* and
- Valentina Escott-Price, PhD1,2,*
- 1MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine & Clinical Neurosciences, Cardiff University, UK
- 2Dementia Research Institute, Cardiff University, UK
- 3Dementia Research Institute, University College London, UK
- 4Neuroscience and Physiology, State University of New York, USA
- ↵*Corresponding Authors Valentina Escott-Price, Tel. +44 2920 688429, Address: Hadyn Ellis Building, Cardiff University, Maindy Road, Cardiff, CF24 4HQ, UK, e-mail: escottpricev{at}cardiff.ac.uk, John Hardy, Tel. +44 2031 086802, Address: UCL Cruciform Building, Gower Street, London, WC1E 6BT, UK, e-mail: j.hardy{at}ucl.ac.uk
Posted April 28, 2022.
Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer’s disease pathogenesis
